XXXX : outcome and prognostic factors in 50 cases from a single centre.

@entity1 @entity8 @entity1252 @entity740 @entity177 @entity1988 @entity454
BACKGROUND: @entity454 ( @entity454 ) is an important cause of morbidity and mortality in @entity1 with @entity1252 ( @entity1252 ). OBJECTIVES: To analyze the outcome and prognostic factors of renal transplantation in @entity1 with @entity454 due to @entity1252 from January 1986 to December 2013 in a single center. RESULTS: Fifty renal transplantations were performed in 40 @entity1252 @entity1 (32 female (80%), mean age at transplantation 36  10.4 years). The most frequent @entity8 was type IV (72.2%). @entity177 occurred in a total of 15 (30%) transplantations and the causes of graft failure were @entity740 (n=12), acute rejection (n=2), and chronic humoral rejection (1). The death-censored graft survival rates were 93.9% at 1 year, 81.5% at 5 years, and 67.6% at the end of study. The presence of deceased donor allograft (P=0.007) and positive anti-HCV antibodies (P=0.001) negatively influence the survival of the renal transplant. The @entity1 survival rate was 91.4% at the end of the study. Recurrence of @entity1988 in renal allograft was observed in one @entity1 . CONCLUSION: Renal transplantation is a good alternative for renal replacement therapy in @entity1 with @entity1252 . In our cohort, the presence of anti-HCV antibodies and the type of donor source were related to the development of graft failure.
